Is It Okay to Take Natrol Melatonin Every Day?

You have a bottle of Natrol on the nightstand, you have been reaching for it most nights, and somewhere around week six the question arrives: is this actually fine?

It is a fair thing to ask. Melatonin use among US adults more than quintupled between 1999 and 2018, climbing from 0.4% to 2.1% across 55,021 people surveyed, and a lot of them never planned to still be taking it months later.

The short version: the brand on the bottle is not what decides this. Three other things do.

Contents

• The short answer, and what it actually depends on
• What the research says about taking it every night
• The 2025 heart failure finding, in proportion
• Why daily use raises the stakes on what is in the bottle
• Format changes what "every day" means
• If you have already been taking it nightly for months
• Why verification matters more when it is every night
• Frequently asked questions
• The bottom line
• Research references

The short answer, and what it actually depends on

For most healthy adults, taking melatonin nightly for a stretch of weeks is well-trodden ground, and the brand is close to irrelevant to that judgement. Melatonin is a single molecule. A tablet from one company and a liquid from another deliver the same compound, which is why no honest answer to this question can hinge on the logo.

What the logo cannot tell you is how the dose behaves once you have swallowed it. A 2026 clinical review puts it bluntly: melatonin preparations differ in release profile, route of administration, pharmacokinetics and product quality, and the result is inconsistent effects and unpredictable blood levels. So the things that move the answer are duration, your own health situation, and the format you are using.

We have covered the general safety question in depth elsewhere — if that is what you came for, read is it bad to take melatonin every night and what happens if you take melatonin every night, which walk through the main safety questions in full.

This article does something narrower. It answers the version of the question you are actually asking when you have committed to one specific product and been taking it for months, because two things change at that point that do not apply to a one-off dose.

What the research says about taking it every night

The best evidence on sustained nightly use comes from a randomised, placebo-controlled trial that enrolled 791 adults aged 18 to 80 with primary insomnia. After an initial double-blind phase, participants continued on nightly treatment or placebo for a further 26 weeks. It reported sustained benefit and no safety signal over that period, and notably the effect did not wear off — which distinguishes melatonin from several prescription sleep medications.

One caveat matters more here than it usually would. That trial tested prolonged-release melatonin, a tablet engineered to release its payload gradually in the gut. It is not a verdict on fast-dissolve tablets, gummies or liquids, which behave differently. If the argument of this article is that format changes the outcome, then the best long-term safety evidence we have is evidence about one particular format — and it is worth saying so plainly rather than quietly borrowing its reassurance for every product on the shelf.

Twenty-six weeks is roughly six months, and that is close to the outer edge of high-quality evidence. Beyond it, the research record gets thin fast. That is not the same as evidence of harm; it is an absence of data, and the two are easy to confuse when you are reading headlines.

Side effects reported across trials tend to be mild and self-limiting. Headache, dizziness, nausea and next-morning grogginess are the ones that come up most often. Our melatonin side effects and safety guide covers the full profile.

Worth knowing: the American Academy of Sleep Medicine's 2017 clinical practice guideline, which graded the randomised evidence using the GRADE framework, issued recommendation 12 — a weak suggestion that clinicians not use melatonin for sleep onset or sleep maintenance insomnia in adults. Read that carefully. It is a judgement that the evidence for efficacy is weak, not a safety warning.

There is a second thing worth reading carefully. The task force noted that its melatonin recommendation rested on trials of 2 mg doses. Most of what sits on a pharmacy shelf today is considerably stronger than that, which means the guideline is a verdict on a dose few people are actually taking.

The 2025 heart failure finding, in proportion

In November 2025, researchers presented an analysis of 130,828 adults with insomnia drawn from a global health-records network. Among the 65,414 with a year or more of recorded melatonin use, heart failure was diagnosed in 4.6% over the following 5 years, against 2.7% in a matched comparison group.

That is a real finding and it deserves to be taken seriously. It also carries three limitations that matter a great deal. It has not been peer-reviewed as a full paper. It is observational, so it cannot show that melatonin caused the difference. And the exposure measure depends on prescriptions appearing in medical records — in the United States melatonin is sold over the counter, so an unknown number of people counted as non-users were almost certainly taking it.

There is also a confounding problem that is hard to solve: every person in both groups had insomnia, and insomnia is itself associated with cardiovascular risk. Sorting the effect of the supplement from the effect of the condition it treats is genuinely difficult with this kind of data.

The proportionate response is not alarm. It is that open-ended nightly use — the kind that runs past 12 months without anyone revisiting it — is worth a conversation with your doctor, particularly if you have an existing heart condition.

Why daily use raises the stakes on what is in the bottle

Here is the part that genuinely changes when you go from occasional to daily, and it is the strongest practical argument in this whole article. A single dose that misses its label claim is a non-event. The same miss, in the same direction, repeated 365 times, is a different proposition entirely.

Researchers at the University of Guelph analysed 31 melatonin supplements bought from ordinary shops and pharmacies. More than 71% fell outside a 10% margin of their stated content. Actual melatonin ranged from 83% below the label claim to 478% above it. Batches of the same product varied from one another by as much as 465%, and some products contained undeclared serotonin.

Two things to be clear about. That study did not name the products it tested, so it says nothing about any particular brand. And it covered tablets, capsules and liquids as a category, published in 2017 — it is a statement about how the supplement category is regulated, not an accusation.

Gummies are a separate and worse case. A 2023 analysis of 25 melatonin gummy products found 22 of them — 88% — inaccurately labelled, with measured content between 74% and 347% of what the label declared, and one containing no detectable melatonin at all. If your daily habit is a gummy, that figure is the one that applies to you.

Format changes what "every day" means

Natrol sells melatonin in several formats, and so does most of the category. That variety is not cosmetic — it changes how the dose behaves across a night, which in turn changes whether nightly use is doing what you want it to do.

Swallowed melatonin is poorly and unpredictably absorbed. A 2026 review of melatonin delivery puts absolute oral bioavailability in the range of 2.5% to 33%, with extensive first-pass metabolism in the liver as the main reason: roughly 90% of what reaches circulation is broken down by liver enzymes before it can do anything. On top of that, how much gets through varies with age, smoking, caffeine and other medications. Most of what you swallow does not arrive intact.

That variability has a practical consequence for daily users:

• A fast-dissolve format front-loads the dose — useful for trouble falling asleep, less relevant if you wake at 3am
• A time-release format spreads it out — in a head-to-head crossover study, a sustained-release capsule produced a lower peak concentration and a half-life about five times longer than the immediate-release version. The reverse trade-off, and a mismatch if your problem is sleep onset
• Sublingual absorption begins before the dose reaches the stomach, partially bypassing first-pass liver metabolism
• Gummies carry the 88% labelling problem on top of everything else

Taking the wrong format nightly for 6 months is a slow, invisible way to conclude that melatonin does not work for you, when the real issue was a format-to-problem mismatch. Our comparison of melatonin supplement forms sets out which format suits which sleep pattern, and our Natrol and liposomal melatonin comparison looks at how the two approaches differ on route of absorption and verification.

If you have already been taking it nightly for months

First, do not panic-stop. There is no strong evidence that melatonin produces the escalating tolerance associated with prescription hypnotics, and the 26-week trial found no fading of effect. Stopping abruptly out of worry is rarely the right move.

Second, treat it as a checkpoint rather than a verdict. Sleep problems change over 6 or 12 months, and it is easy to keep taking something out of habit long after the reason has gone. The two questions worth asking are whether it is still helping, and whether the thing that started the problem is still there. Our guide to melatonin tolerance, dependency and long-term use covers what the research shows.

Third, if you decide to step back, do it deliberately. We cover the arguments on both sides in do you need a break from melatonin and how many nights in a row you can take melatonin, and there is a practical walkthrough in how to stop taking melatonin every night.

Fourth, and this is the one people skip: if you take prescription medication, check the interactions. Melatonin interacts with several common drug classes, and our melatonin drug interactions guide sets out which ones and why.

Why verification matters more when it is every night

If the argument above lands, the conclusion is not that you need a different brand. It is that daily use makes verification worth more than the number printed on the front of the box — and that is the standard any product should be held to, ours included.

Bio Absorb Nutraceuticals makes Liposomal Liquid Melatonin, a sublingual liquid rather than a tablet or gummy. The melatonin is encapsulated in phospholipid spheres, and the dose is taken under the tongue, where absorption begins before it reaches the stomach and partially bypasses the first-pass liver metabolism that removes most of a swallowed dose. That is a mechanistic difference in route, not a claim of measured superiority over any competitor — no head-to-head trial of this product against another brand exists, and we are not going to imply one does.

On the verification point, which is the one that matters most for daily users: every batch is independently third-party tested for purity and potency, with a certificate of analysis available on request. It is manufactured in Canada in a GMP-certified facility, and the formulation is non-GMO, gluten-free, nut-free, dairy-free, corn-free and non-irradiated, in a BPA-free glass bottle that needs no refrigeration. The dropper allows the dose to be adjusted rather than fixed by a tablet's shape.

For current pricing and serving details, see the product page — those figures change, and a number printed in an article goes stale quietly. It is covered by a money-back guarantee.

Frequently asked questions

Is Natrol melatonin safe to take every night?

For most healthy adults, nightly use over a period of weeks is supported by the evidence, and the brand is not the deciding factor — the 26-week trial, run in a cohort of 791 enrolled adults, found no safety signal over that window. The questions that do matter are how long you intend to continue, whether you take other medication, and whether the format suits your particular sleep problem.

Can you build up a tolerance to melatonin?

There is no strong evidence that melatonin produces the escalating tolerance seen with prescription hypnotics, and the 6-month trial specifically found the effect did not diminish. That said, "no tolerance" is not the same as "keep taking it indefinitely without review."

How long is too long to take melatonin daily?

There is no established cut-off, which is itself the honest answer. High-quality evidence extends to roughly 26 weeks, and the 2025 records analysis that raised cardiovascular questions looked specifically at people with 12 months or more of use — so somewhere past the 6-month mark is a sensible point to review it with a doctor rather than continue by default.

Does it matter which melatonin product I take every day?

More than it would for occasional use, yes. When over 71% of 31 tested supplements missed their label claim by more than 10%, a daily habit compounds that gap in a way a one-off dose never does — which makes third-party batch testing worth more than any figure on the packaging.

Should I stop taking melatonin because of the heart failure study?

Not on the strength of that study alone. It is a preliminary, non-peer-reviewed analysis of health records showing a 4.6% versus 2.7% difference in an insomnia population that already carries elevated cardiovascular risk, and it cannot establish cause. If you have an existing heart condition or have been taking melatonin for over a year, raise it with your doctor.

Who should not take melatonin nightly without medical advice?

Anyone who is pregnant or breastfeeding, anyone considering it for a child, and anyone taking prescription medication — melatonin interacts with several common drug classes, which our drug interactions guide sets out in full. Those three groups should treat a doctor's input as a prerequisite rather than an optional extra.

The bottom line

Taking melatonin every day is a question about duration, format and verification, not about which brand is on the bottle — and the honest boundary is that high-quality evidence runs to about 26 weeks, for one particular formulation, and then stops. If you are going to make it a nightly habit, the thing worth being loyal to is a product that proves what is in it, which is why Liposomal Liquid Melatonin is third-party tested on every batch with a certificate of analysis on request. For the full picture, start with our complete evidence-based guide to melatonin for sleep.

Research References

1. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Medicine, Vol. 8 (2010). Randomised placebo-controlled trial enrolling 791 adults aged 18–80, with nightly prolonged-release melatonin continued for 26 weeks, showing sustained efficacy, no diminution of effect and no safety signal over that period.
2. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, Vol. 13, No. 2 (2017). Analysis of 31 commercial supplements finding more than 71% outside a 10% margin of label claim, content ranging from −83% to +478%, lot-to-lot variability up to 465%, and undeclared serotonin in some products.
3. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, Vol. 13, No. 2 (2017). Recommendation 12 issues a weak suggestion against melatonin for sleep onset or sleep maintenance insomnia in adults, on grounds of weak efficacy evidence rather than safety concerns, and notes the recommendation rests on trials of 2 mg doses.
4. Quantity of melatonin and CBD in melatonin gummies sold in the US. JAMA, Vol. 329, No. 16 (2023). Found 22 of 25 gummy products (88%) inaccurately labelled, with measured melatonin between 74% and 347% of the declared quantity and one product containing none.
5. Trends in use of melatonin supplements among US adults, 1999–2018. JAMA, Vol. 327, No. 5 (2022). NHANES analysis of 55,021 adults showing reported melatonin use rising from 0.4% to 2.1%, with a parallel rise in use above 5 mg per day.
6. Comparative pharmacokinetics of sustained-release versus immediate-release melatonin capsules in fasting healthy adults: a randomized, open-label, cross-over study. Pharmaceutics, Vol. 16, No. 10 (2024). Crossover pharmacokinetic comparison in healthy adults in which the sustained-release formulation produced a lower peak concentration and an elimination half-life roughly five times longer than the immediate-release formulation.
7. Overcoming biological barriers: a comprehensive review of advanced melatonin delivery systems for therapeutic applications. International Journal of Medical Sciences, Vol. 23, No. 7 (2026). Reports absolute oral melatonin bioavailability of 2.5% to 33%, attributing the shortfall principally to extensive hepatic first-pass metabolism, with approximately 90% of absorbed melatonin cleared by liver enzymes.
8. Melatonin in clinical practice: grey zones between chronobiology, insomnia and consumer supplementation. Clocks & Sleep, Vol. 8, No. 3 (2026). Clinical review finding that melatonin preparations differ in release profile, route of administration, pharmacokinetics and product quality, producing inconsistent effects and unpredictable plasma concentrations, with oral bioavailability further influenced by age, smoking and caffeine.
9. Abstract 4371606: Effect of long-term melatonin supplementation on incidence of heart failure in patients with insomnia. Circulation, Vol. 152, Suppl. 3 (2025). Propensity-matched analysis of 130,828 adults with insomnia reporting incident heart failure in 4.6% of long-term melatonin users versus 2.7% of matched controls. Conference abstract, not peer-reviewed as a full manuscript.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.